MRK Forum Topics
- All Comments on MRK
- General Discussion on MRK
- Dow 30 Performance Since 7/15 [view article]
- Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse [view article]
- Investing in Dividend Paying Companies [view article]
- HPC Vaccine Inspires Yellow Health Journalism [view article]
- Clarifying the Vytorin Situation: Three Key Questions [view article]
- Just What the Doctor Ordered: Comparing the Pharma ETFs [view article]
- This Week's Key Earnings Reports [view article]
- Tuesday Options Update: MRK, SNDK, TXN, TAP, GTXI, SPF, BRCD, XLF [view article]
- Wall Street Breakfast: Must-Know News [view article]
- Roche's Genentech Offer Sends Ripples Through Biotech [view article]
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF [view article]
- The Top Dividend Paying ETFs and Stocks [view article]
Recent MRK Articles
- Dow 30 Performance Since 7/15
- Just What the Doctor Ordered: Comparing the Pharma ETFs
- Did Merck's Sex and the City Strategy Work?
- Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse
- Clarifying the Vytorin Situation: Three Key Questions
- Tuesday Options Update: MRK, SNDK, TXN, TAP, GTXI, SPF, BRCD, XLF
- Wall Street Breakfast: Must-Know News
- Roche's Genentech Offer Sends Ripples Through Biotech
- HPC Vaccine Inspires Yellow Health Journalism
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
- Full List of Articles »
loading ...
Edwards
Investing in Dividend Paying Companies [view article]
This analysis is further proof, if any were needed, of the wisdom of buying solid companies and planning to hold them for a long time. A refinement of the technique would have been to assume all stocks had DRIPS plans, and you opted for them, which would have been the best pre-retirement strategy.Mind you, not all of the DJIA stocks meet my personal quality criteria, so I would have been more selective. The same holds true today, for example GM. And there are other higher-quality stocks which are not on the DJIA list. Quality is the issue, and dividends are part of the definition of quality. Reply
Investing in Dividend Paying Companies [view article]
430% for 10years. Let's see isn't that 4% a year? What happens if you have reinvested your dividends thru a DRIP? If you had only selection critieria for picking a stock, companies that increase dividends over a long period of time (10 years or more). Google Dividend Aristocrats. ReplyInvesting in Dividend Paying Companies [view article]
Your analysis is worth noting. However, buying this new list near the bottom of the market will surely produce significant gains over the next ten years without any trading. ReplyInvesting in Dividend Paying Companies [view article]
Its funny to see some of those names up there. Its amazing how quick things change. Eastman Kodak for example used to be an icon but is now struggling. ReplyGrowth
Investor
Investing in Dividend Paying Companies [view article]
Interesting analysis. You might also reference one of Jeremy Siegel's research papers where he found out that buying the orginial 500 stocks of the S&P 500 back in 1957 and then doing absolutely nothing for 50 years would have also outperformed the S&P 500 index by 1 percentage point! ReplyTiedeman
Dow 30 Price Targets - Too Much Optimism? [view article]
It is hard to believe how beaten up some of these names have become. But I suspect earnings will be horrible for several quarters. ReplyA Bullish Prognosis for Global Healthcare ETFs [view article]
Gaylord? Are you the guy from Meet the Fockers? ReplyA Bullish Prognosis for Global Healthcare ETFs [view article]
You have much more control over the purchase price if you select a company like Zecco.com.On July 13, BlueOkie wrote:
ETFs have their place. I prefer to buy PFE and JNJ direct thru the transfer agents. No fees! Reply
A Bullish Prognosis for Global Healthcare ETFs [view article]
ETFs have their place. I prefer to buy PFE and JNJ direct thru the transfer agents. No fees! ReplyA Bullish Prognosis for Global Healthcare ETFs [view article]
Looks like HQL would appeal to investors looking for higher risk/reward investments in the healthcare sector. Has about 60% invested in biopharma, med devices & diagnostics. Of the top holdings Biomarin (BMRN) has done very well while Acadia Pharma (ACAD) is the worst performer. The fund trades at 15% discount to its NAV with a 9.4% distribution rate. See the full profile at www.etfconnect.com/sel... ReplyA Bullish Prognosis for Global Healthcare ETFs [view article]
I think the long-overdue rotation into healthcare is starting to occur and would favor RXL going forward. The top holdings are JNJ (11%), PFE (8%), MRK (5%), and ABT (4.7%) which should fare well with above-average dividend yields and products that people use regardless of the overall economy. JNJ is actually close to its 52-week high while ABT is mid-range and MRK/PFE are close to their lows. The more it appears a prolonged recession is likely; the better these stocks and RXL should perform. ReplyDaniel
A Bullish Prognosis for Global Healthcare ETFs [view article]
Could you comment, or look into ProShares (RXL. RXL moves 200% relative to the health care basket of stocks. The inverse or short position version is (RXD). RE: RXD if the health sector goes down, then RXD will go up by about 200% I have been using them both depending which way is the momentum of health care looks. I have done better with the short RXD than going long on RXLGaylord Daniel Reply
A Bullish Prognosis for Global Healthcare ETFs [view article]
Have you looked at HQL? ReplyDow 30 Earnings Reports [view article]
Could not agree more. Too small sample size to be statistically representative. ReplyBig Pharma Stocks: Real Rally or Just a One Day Wonder? [view article]
Hi Mike, good article. I'm optimistic about drug stocks. I'm long PFE and have been feeling quite a bit of pain, but I think all of the bad news is cooked into most pharmaceutical stocks. I'm willing to keep adding to my position on dips and collect the nice dividend until the sector resuscitates. Reply